National Immunisation Programme: slightly more cases in 2022, but fewer than before the COVID-19 pandemic
In 2022, a slightly higher number of people in the Netherlands contracted diseases covered by the National Immunisation Programme (NIP) compared to 2021. This increase is likely due to the easing of coronavirus measures, such as social distancing.
European prize for mobile vaccination units
The Netherlands’ mobile vaccination units (prikbussen) have been selected as a best-practice method for the European project ‘Overcoming Obstacles to Vaccination’.
Provisional figures on participation in the National Immunisation Programme
According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).
Side effect reports National Immunisation Programme 2021
Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
Participation in National Immunisation Programme shows slight decrease
Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine
Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.